Microbial resistance: Lessons from the EPIC study

Intensive Care Medicine, Supplement

Volumn 26, Issue 1, 2000, Pages

  Vincent, J L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; METICILLIN; TEICOPLANIN; UREIDOPENICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ASEPSIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; ENTEROBACTER; EUROPE; FUNGUS; HAND WASHING; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; REGIONALIZATION; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; EUROPE; FEMALE; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 0034030439     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Anonymous (1995) Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother [Suppl]: 1-23
2. Hiramatsu K (1998) The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med 104: 7S-10S
3. Smith TL, Pearson ML, Wilcox KR (1999) Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340: 493-501
4. Ariza J, Pujol M, Cabo J (1999) Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353: 1587-1588
5. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D (1998) Antifungal drug resistance in pathogenic fungi. Med Mycol 36 Suppl 1: 119-128
6. Vincent JL, Bihari D, Suter PM (1995) The prevalence of nosocomial infection in intensive care units in Europe - the results of the EPIC study. JAMA 274: 639-644
7. Vincent JL, Suter P, Bihari D, Bruining H (1997) Organization of intensive care units in Europe: Lessons from the EPIC study. Intensive Care Med 23: 1181-1184
8. Ibelings MM, Bruining HA (1998) Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 164: 411-418
9. Jarvis WR, Edwards JR, Culver DH (1991) Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 91: 185S-191S
10. Kollef MH (1999) The prevention of ventilator-associated pneumonia. N Engl J Med 340: 627-634
11. Vincent JL (1999) Prevention of nosocomial bacterial pneumonia. Thorax (in press)
12. Buirma RJ, Horrevorts AM, Wagenvoort JH (1991) Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study. Scand J Infect Dis Suppl 78: 35-44
13. Shah PM, Asanger R, Kahan FM (1991) Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals. Scand J Infect Dis [Suppl] 78: 22-34
14. Verbist L (1991) Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study. Scand J Infect Dis Suppl 78: 45-53
15. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I (1994) Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13: 50-55
16. Chen HY, Yuan M, Ibrahim-Elmagboul IB, Livermore DM (1995) National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 35: 521-534
17. Livermore DM, Yuan M (1996) Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 38: 409-424
18. Jarlier V, Fosse T, Philippon A (1996) Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med 22: 1057-1065
19. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ (1999) Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 281: 67-71
20. Eltahawy AT (1997) Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility. J Chemother 9: 403-410
21. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JEJ, Gaynes RP (1998) Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 19: 388-394
22. Marione WJ (1998) Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 19: 539-545
23. Kim WJ, Park SC (1998) Bacterial resistance to antimicrobial agents: an overview from Korea. Yonsei Med J 39: 488-494
24. Schaberg DR, Dillon WI, Terpenning MS, Robinson KA, Bradley SF, Kauffman CA (1992) Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother 36: 2533-2535
25. Archibald L, Phillips L, Monnet D, McGowan JEJ, Tenover F, Gaynes R (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24: 211-215
26. Solomkin JS (1996) Antimicrobial resistance: An overview. New Horiz 4: 319-320
27. Linden PK, Pasculle AW, Manez R (1996) Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 22: 663-670
28. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP (1996) Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 23: 1234-1239
29. Stosor V, Peterson LR, Postelnick M, Noskin GA (1998) Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 158: 522-527
30. Krcmery VJ, Spanik S, Krupova I (1998) Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study. J Chemother 10: 320-325
31. Conterno LO, Wey SB, Castelo A (1998) Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19: 32-37
32. Ballow CH, Schentag JJ (1992) Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 15: 37S-42S
33. White ACJ, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB (1997) Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 25: 230-239
34. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V (1997) Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 156: 1040-1048
35. Goldmann DA, Weinstein RA, Wenzel RP (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 275: 234-240